CN Stock MarketDetailed Quotes
688710 Shanghai InnoStar Bio-tech
- 38.45
- -0.25-0.65%
Trading Nov 27 09:33 CST
5.42BMarket Cap36.97P/E (TTM)
38.80High38.41Low557.05lotVolume38.52Open38.70Pre Close2.15MTurnover0.21%Turnover Ratio27.88P/E (Static)140.98MShares50.1352wk High2.29P/B1.02BFloat Cap22.5252wk Low46.44Limit Up26.50MShs Float50.13Historical High30.96Limit Down1.01%Amplitude22.52Historical Low--Dividend TTM38.66Avg Price378.80lotAsk--Div YieldTTM100Lot Size155.02lotBid
Shanghai InnoStar Bio-tech Key Stats
EPS
According to the latest financial report of Shanghai InnoStar Bio-tech, the latest earnings per share (TTM) for the company is 1.21. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Shanghai InnoStar Bio-tech's latest financial report to see how much their book value per share (BVPS) is currently at 16.83.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Shanghai InnoStar Bio-tech shows that the company's current ratio is 3.65, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Shanghai InnoStar Bio-tech, the quick ratio is 3.04, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Shanghai InnoStar Bio-tech? The latest ROE figure is 6.66%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Shanghai InnoStar Bio-tech, the total asset return on investment (ROA) is 4.12%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Shanghai InnoStar Bio-tech's latest financial report to see how their gross margin is doing - currently at 36.29%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Shanghai InnoStar Bio-tech, the net profit margin is 14.10%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data